Hospital of the University of Pennsylvania-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2011

  1. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Blood, Vol. 117, Núm. 12, pp. 3294-3301